- cafead   Feb 27, 2024 at 11:32: PM
via Some existing investors are pumping $500 million into Denali Therapeutics to help support ongoing research and development activities, including its blood-brain barrier crossing therapeutics. The biotech announced the sale of more of its shares through a private investment in public equity financing Tuesday.
article source
article source